Related Experiment Video
Updated: Jul 9, 2026
Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy
Published on: October 16, 2013
A screening test for the prediction of Dravet syndrome before one year of age
Junri Hattori1, Mamoru Ouchida, Junko Ono
1Department of Child Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Insights
A new screening test helps predict Dravet syndrome in infants before age one. Early identification of risk factors and SCN1A gene mutations can aid diagnosis.
Area of Science:
- Pediatric Neurology
- Clinical Genetics
Background:
- Dravet syndrome is a severe form of epilepsy.
- Early diagnosis is crucial for effective management.
Purpose of the Study:
- To develop a screening tool for predicting Dravet syndrome in infants before their first birthday.
- To utilize clinical characteristics and SCN1A mutation analysis for prediction.
Main Methods:
- Enrolled 96 infants with febrile seizures before age one.
- Compared clinical features of Dravet syndrome (n=46) and non-Dravet syndrome (n=50) groups.
- Analyzed SCN1A gene exons and assigned risk scores based on clinical factors.
Main Results:
- Significant risk factors for Dravet syndrome included early onset (<7 months), frequent seizures (>=5), and prolonged seizures (>10 min).
- Hemiconvulsions, partial seizures, myoclonic seizures, and hot water-induced seizures were also predictive.
- A clinical score of >=6 indicated high risk; SCN1A mutations were more frequent in Dravet syndrome patients.
Conclusions:
- A simple screening test can predict Dravet syndrome in infants before one year of age.
- Pediatricians can use this tool for early risk assessment.
- A clinical score of >=6 warrants SCN1A mutation analysis for confirmation.
Purpose:
Our aim was to develop a screening test to predict Dravet syndrome before the first birthday based on the clinical characteristics of infants and the SCN1A mutation analysis.
Methods:
Ninety-six patients who experienced febrile seizures before the age of one were enrolled. The patients were divided into two groups-the Dravet syndrome group (n = 46) and the non-Dravet syndrome group (n = 50). We compared the clinical characteristics before one year of age of the two groups. We analyzed all coding exons of the SCN1A gene by the direct sequencing method. Scores from 0 to 3 were assigned to each risk factor based on the odds ratio and p-value.
Results:
An age of onset of febrile seizure
Discussion:
This simple screening test was designed to be used by general pediatricians. It could help to predict Dravet syndrome before one year of age. If the sum of the clinical risk score is >or= 6, then the performance of an SCN1A mutation analysis is recommended.
